HP200 is now sold worldwide for the treatment of Parkinson's disease, under the brand name Zandopa. It is one of the first plant -based formulations to have received approval from the United States Food and Drug Administration (FDA).
Mucuna seeds in various forms, powdered, water-based, in combination with other herbs, capsules, pellets, shakes, etc. are marketed universally in pharmacies and health supplement stores.
Leading U.S companies that market Mucuna include Physicians Formulas and Solaray. In the US for example, high selling brands of Mucuna used against Parkinson's are Physicians Formulas and even Zandopa, which is imported from India via mail orders. The general doses of the former are 1 or 2 tablets of 400mg Mucuna (seed extracts), per day. There are various health websites dedicated to the regular users of the herb.